Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
47.94
+4.32 (9.90%)
At close: Dec 20, 2024, 4:00 PM
49.00
+1.06 (2.21%)
After-hours: Dec 20, 2024, 5:38 PM EST
Twist Bioscience Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 52.33, with a low estimate of 35 and a high estimate of 60. The average target predicts an increase of 9.16% from the current stock price of 47.94.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TWST stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
Buy | 4 | 4 | 4 | 4 | 4 | 5 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 9 | 9 | 8 | 8 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wolfe Research | Wolfe Research | Buy Initiates $60 | Buy | Initiates | $60 | +25.16% | Dec 13, 2024 |
TD Cowen | TD Cowen | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +20.98% | Nov 26, 2024 |
Barclays | Barclays | Buy Maintains $55 → $52 | Buy | Maintains | $55 → $52 | +8.47% | Nov 19, 2024 |
Scotiabank | Scotiabank | Buy Maintains $50 → $54 | Buy | Maintains | $50 → $54 | +12.64% | Nov 19, 2024 |
Baird | Baird | Buy Maintains $46 → $48 | Buy | Maintains | $46 → $48 | +0.13% | Nov 19, 2024 |
Financial Forecast
Revenue This Year
380.81M
from 312.97M
Increased by 21.67%
Revenue Next Year
447.54M
from 380.81M
Increased by 17.52%
EPS This Year
-2.40
from -3.60
EPS Next Year
-1.73
from -2.40
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 394.8M | 474.0M | 588.2M | ||
Avg | 380.8M | 447.5M | 535.5M | ||
Low | 363.2M | 415.1M | 489.7M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 26.1% | 24.5% | 31.4% | ||
Avg | 21.7% | 17.5% | 19.7% | ||
Low | 16.0% | 9.0% | 9.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -2.19 | -1.37 | -0.77 |
Avg | -2.40 | -1.73 | -1.15 |
Low | -2.75 | -2.12 | -1.44 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.